| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $518.2M | $440.1M | $378.1M |
| YoY Revenue Growth % | +17.8% | +16.4% | — |
| Gross Profit | $312.9M | $258.3M | — |
| Gross Margin % | 60.4% | 58.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $30.3M | $15.2M | $33.4M |
| Operating Margin % | 5.8% | 3.4% | 8.8% |
| Net Income (GAAP) | $20.0M | $9.9M | $26.0M |
| EBITDA (Normalized) | $99.6M | $60.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $59.3M | $29.3M | $25.6M |
| Capital Expenditures (CapEx) | $86.6M | $56.9M | — |
| Free Cash Flow (FCF) | -$27.3M | -$27.6M | $25.6M |
| FCF Margin % | -5.3% | -6.3% | 6.8% |
| Return on Invested Capital (ROIC %) | 14.0% | 10.1% | — |
| Cash & Short-Term Equivalents | $28.5M | $59.3M | — |
| Total Debt (Short + Long Term) | $0 | $0 | — |
| Total Stockholders' Equity | $199.7M | $178.3M | — |